Glialogix, Fast Forward Partner for MS Therapies

Placental Cells May Present New Treatment for MS
Placental Cells May Present New Treatment for MS
Glialogix has partnered with Fast Forward to accelerate the development of therapies to treat multiple sclerosis.

Glialogix has partnered with the National Multiple Sclerosis Society’s Fast Forward nonprofit to develop treatment therapies for progressive MS, including the acceleration of clinical trials of its GLX1112 oral therapy.

READ FULL ARTICLE Curated publisher From PharmiWeb.com